You are reading 1 of 2 free-access articles allowed for 30 days
2 CPD Hours
Dr Michael Lockhart, Endocrinology SpR, and Prof Diarmuid Smith, Consultant Diabetologist and Endocrinologist, Academic Department of Diabetes and Endocrinology, Beaumont Hospital and RCSI Medical School
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune condition characterised by autoimmune destruction of the pancreatic beta cell. It is associated with macrovascular and microvascular complications. Tight glycaemic control has been shown to ameliorate the long-term complications of T1DM. Monitoring glucose levels frequently helps patients to achieve more intensive glycaemic control. Fingerprick blood glucose monitoring has traditionally been the most commonly used method. More recently, continuous glucose monitoring (CGM) systems have shown improvements in glycaemic control, reduced frequency of hypoglycaemia, improved recognition of hypoglycaemia and an improvement in quality of life. This module will summarise the evidence for CGM and its current role in the management of patients with T1DM.
To earn CME credit, follow these steps:
Each DoctorCPD module is designed to be completed within the time designated on the Module Introduction page. This is an estimate of the maximum time required to complete the specific module and is determined by the format and content of the module. Users should claim only those credits that reflect the time actually spent on the activity.
To successfully earn credit, participants must complete the activity online, and receive a minimum score of 70% on the post-module assessment.
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...